查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1442914

神經內視鏡 - 全球市場考量、競爭格局、市場預測 (2030)

Neuroendoscopy - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

預計2024-2030年期間，全球神經內視鏡市場規模將以4.91%的複合年增長率大幅成長。神經內視鏡檢查的需求主要是由腦腫瘤等神經系統疾病盛行率的上升所推動的。此外，對微創手術的需求不斷增長以及與神經內視鏡手術相關的各種優勢是2024-2030年預測期內市場成長的主要因素。

神經內視鏡市場動態

根據American Society of Clinical Oncology（ASCO）(2023) 的數據，預計 2020 年全球約有 308,102 人被診斷出患有原發性腦部或脊髓腫瘤。腦腫瘤佔所有原發性中樞神經系統 (CNS) 腫瘤的 85% 至 90%。因此，腦腫瘤等神經系統疾病盛行率的上升產生了對此類神經系統疾病的治療和管理的需求，從而導致神經內視鏡市場的積極增長。

神經內視鏡市場的另一個驅動因素是對微創手術的需求不斷增長以及與神經內視鏡手術相關的各種好處。神經內視鏡的微創性質通常可以減少手術過程中的失血，從而減少輸血需求並降低整體手術風險。此外，神經內視鏡可實現高解析度成像，使外科醫生能夠精確導航和治療目標區域。此外，較小的切口使身體組織在手術過程中接觸到的外部污染物較少，降低了感染的風險。因此，與神經內視鏡手術相關的各種好處以及對微創手術的需求不斷增長是推動神經內視鏡市場在預測期內成長的主要因素。

然而，與神經內視鏡手術和設備相關的高成本以及熟練的神經科醫生和內視鏡醫師的短缺是可能限制神經內視鏡市場增長的主要限制因素。

神經內視鏡市場細分分析

就神經內視鏡市場的產品細分而言，預計到2023年，柔性神經內視鏡類別將在神經內視鏡市場中佔重要的收入佔有率。這可能是由於柔性神經內視鏡提供的各種優勢。柔性神經內視鏡是具有靈活設計的專用醫療設備，能夠導航大腦內彎曲且複雜的路徑，從而增強對複雜結構的存取。此外，柔性神經內視鏡提供的靈活性可實現微創手術，減少大切口的需要，從而減少組織損傷、減輕疼痛並加快恢復時間。此外，這些內視鏡的靈活性和可操作性使外科醫生能夠到達大腦、心室和脊髓的複雜區域。

因此，由於上述因素，柔性神經內視鏡類別預計將出現顯著成長，從而推動預測期內整體神經內視鏡市場的成長。

北美預計將主導整個神經內視鏡市場

在所有地區中，預計到 2023 年北美將佔神經內視鏡市場的最高佔有率。這是因為患有腦腫瘤等各種神經系統疾病的患者很多。此外，發達和先進的醫療基礎設施、技術進步以及產品開發和發佈方面非常強勁的市場是北美神經內視鏡市場的成長動力。

根據American Society of Cancer (2023) 提供的數據，預計 2023 年美國將診斷出約 24,810 例腦部和脊髓腫瘤。此外，American Society of Clinical Oncology（ASCO） (2023) 的數據估計，2023 年美國將有 5,230 名 20 歲以下兒童被診斷出患有腦部和脊髓腫瘤。因此，各種神經系統疾病的盛行率不斷上升，產生了對這些疾病的治療和管理的需求，導緻美國神經內視鏡市場的積極增長，從而促進了內視鏡市場的發展。

本報告提供了全球神經內視鏡市場的研究和分析，包括市場規模和預測、驅動因素和挑戰以及公司和產品概況。

目錄

第一章 神經內視鏡市場報告簡介

第二章神經內視鏡市場概要

  • 調查範圍
  • 市場概況
  • 競爭評估

第三章 監管分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第四章神經內視鏡市場關鍵因素分析

  • 神經內視鏡市場的驅動因素
  • 神經內視鏡市場的限制與挑戰
  • 神經內視鏡市場機會

第五章神經內視鏡市場波特五力分析

第六章 神經內視鏡市場佈局

  • 依產品
    • 硬質神經內視鏡
    • 柔性神經內視鏡
  • 依用途
    • 鼻腔
    • 腦室內
    • 經顱的
  • 使用性別
    • 可重複使用的
    • 拋棄式
  • 依最終用戶
    • 醫院
    • 門診手術中心
    • 其他
  • 區域
    • 北美
    • 歐洲
    • 亞太地區
    • 其他地區

第七章神經內視鏡市場公司與產品概況

  • Adeor Medical AG
  • Machida Endoscope Co. Ltd
  • B. Braun SE
  • Schindler Endoskopie Technologie GmbH
  • Clarus Medical LLC
  • KARL STORZ
  • Locamed Ltd.
  • Ackermann Instrumente GmbH
  • Tonglu Wanhe Medical Instruments Co., Ltd.
  • Renishaw plc.
  • Cliniva Healthcare
  • Advin Healthcare
  • Aesculap Inc.
  • ClearMind Biomedical

第8章 KOL觀點

第9章 專案方法

第10章 DelveInsight服務內容

第 11 章關於 DelveInsight

第 12 章免責聲明，聯絡我們

Product Code: DIMDCL0700

Neuroendoscopy Market By Product (Rigid Neuroendoscopes And Flexible Neuroendoscopes), Application (Transnasal Neuroendoscopy, Intraventricular Neuroendoscopy, And Transcranial Neuroendoscopy), Usability (Reusable And Disposable) End-User (Hospitals, Ambulatory Surgical Centers, And Others) and geography is expected to grow at a steady CAGR forecast till 2030 owing to the rising prevalence of neurological disorders, growing demand for minimally invasive procedures and various advantages associated with neuroendoscopic procedures

The global Neuroendoscopy Market is poised for significant growth, projected to achieve a remarkable Compound Annual Growth Rate (CAGR) of 4.91% during the forecast period from 2024 to 2030. The demand for neuroendoscopy is primarily being boosted by the rising prevalence of neurological disorders such as brain tumors. Additionally, the growing demand for minimally invasive procedures and various advantages associated with neuroendoscopic procedures are some of the key factors that are contributing to the growth of the neuroendoscopy market during the forecast period from 2024-2030.

Neuroendoscopy Market Dynamics:

As per data published by the American Society of Clinical Oncology

(ASCO) 2023, it was estimated that around 308,102 people were diagnosed with a primary brain or spinal cord tumor in 2020, globally. Of these, brain tumors accounted for 85% to 90% of all primary central nervous system (CNS) tumors. Thus the rising prevalence of neurological disorders such as brain tumors, will create a need for the treatment and management of such neurological disorders, thus resulting in the positive growth of the Neuroendoscopy market.

Another driver for the Neuroendoscopy market is the rising need for minimally invasive procedures and various advantages associated with neuroendoscopy procedures. The minimally invasive nature of neuroendoscopy often results in less blood loss during procedures, reducing the need for blood transfusions and lowering the overall surgical risk. Additionally, neuroendoscopy allows high-resolution imaging enabling surgeons to navigate and treat targeted areas with great accuracy. Further, the smaller incisions in the procedures reduce the risk of infection, as there is less exposure of internal tissue to external contaminants during the procedure. Thus, the various advantages associated with neuroendoscopy procedures and the growing demand for minimally invasive procedures are some of the key factors that will eventually boost the growth of the Neuroendoscopy market during the forecast period.

However, the high cost associated with neuroendoscopy procedures and devices and the shortage of skilled neurologists and endoscopists, are some of the key constraints that may limit the growth of the Neuroendoscopy market.

Neuroendoscopy Market Segment Analysis:

Neuroendoscopy Market by Product (Rigid Neuroendoscopes and Flexible Neuroendoscopes), Application (Transnasal Neuroendoscopy, Intraventricular Neuroendoscopy, and Transcranial Neuroendoscopy), Usability (Reusable and Disposable) End-User (Hospitals, Ambulatory Surgical Centers, and Others) and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product segment of the Neuroendoscopy market, the Flexible Neuroendoscopy category is estimated to amass a significant revenue share in the Neuroendoscopy Market in 2023. This can be attributed to the various advantages provided by Flexible Neuroendoscopy. Flexible Neuroendoscopes are specialized medical instruments that possess flexible design providing the ability to navigate through the curved and intricate pathways within the brain providing enhanced access to complex structures. Additionally, the amount of flexibility provided by the flexible neuroendoscopes enables minimally invasive surgical procedures, reducing the need for large incisions, thus resulting in less tissue damage, reduced pain, and quicker recovery time. Further, the flexibility and maneuverability of these endoscopes allow surgeons to reach complex areas in the brain, ventricles, or spinal cord, which might be challenging to access with rigid instruments.

Therefore, owing to the above-mentioned factors, the Flexible Neuroendoscopy category is expected to register significant growth, thereby driving the growth of the overall Neuroendoscopy market during the forecast period.

North America is expected to dominate the overall Neuroendoscopy Market:

North America is expected to account for the highest proportion of the Neuroendoscopy Market in 2023, out of all regions. This is due to the presence of a large patient pool suffering from various neurological disorders such as brain tumors. Additionally, the presence of developed and sophisticated healthcare infrastructure, rising technological advancements, and a highly potent market in terms of product development, and launches are some of the factors driving the growth of the Neuroendoscopy Market in North America.

According to the data provided by the American Society of Cancer 2023, it was estimated that around 24,810 cases (14,280 in males and 10,530 in females) of brain and spinal cord tumors were diagnosed in the United States, in the year 2023. Additionally, as per the data provided by the American Society of Clinical Oncology (ASCO) 2023, it was estimated that 5,230 children under the age of 20, were diagnosed with brain and spinal cord tumors in the United States, in the year 2023. Thus, the rising prevalence of various neurological disorders will create a need for the treatment and management of these disorders, thus resulting in the positive growth of the Neuroendoscopy Market in the United States, which will eventually propel the Neuroendoscopy market in North America.

Further, various key product launches and product approvals in the region are some of the other factors that are influencing the positive growth of the market in North America. For example, in January 2021, the US FDA granted 510k clearance to ClearMind Biomedical's new neuroendoscope, the Axonpen System.

Therefore, the factors mentioned above, and with the increasing product launches and product approvals in the region, are the factors responsible for driving the overall market for Neuroendoscopy in North America during the forecast period.

Neuroendoscopy Market Key Players:

Some of the key market players operating in the Neuroendoscopy market include Adeor Medical AG, Machida Endoscope Co. Ltd, B. Braun SE, Schindler Endoskopie Technologie GmbH, Clarus Medical LLC, KARL STORZ, Locamed Ltd., Ackermann Instrumente GmbH, Tonglu Wanhe Medical Instruments Co., Ltd., Renishaw plc, Cliniva Healthcare, Advin Healthcare, Aesculap Inc., ClearMind Biomedical, and others.

Recent Developmental Activities in the Neuroendoscopy Market:

  • In August 2021, ClearPoint Neuro Inc. entered into a strategic and commercial partnership with German-based surgical equipment leader Adeor Medical AG.
  • In January 2021, the US FDA granted 510k clearance to ClearMind Biomedical's new neuroendoscope, the Axonpen System.

Key Takeaways from the Neuroendoscopy Market Report Study

  • Market size analysis for current Neuroendoscopy Market size (2023), and market forecast for 6 years (2024-2030)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the global Neuroendoscopy market.
  • Various opportunities available for the other competitors in the Neuroendoscopy Market space.
  • What are the top-performing segments in 2023? How these segments will perform in 2030?
  • Which are the top-performing regions and countries in the current Neuroendoscopy market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for Neuroendoscopy market growth in the coming future?

Target Audience who can be benefited from this Neuroendoscopy Market Report Study

  • Neuroendoscopy product providers
  • Research organizations and consulting companies
  • Neuroendoscopy market-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and Traders dealing in Neuroendoscopy
  • Various end-users who want to know more about the Neuroendoscopy Market and the latest technological developments in the Neuroendoscopy Market.

Frequently Asked Questions for the Neuroendoscopy Market:

1. What is meant by Neuroendoscopy?

Neuroendoscopy is a medical procedure, which is performed using an endoscope. An endoscope is a thin, flexible tube with a light and a camera placed at its tip, is used to visualize and perform surgical interventions within the brain, and spinal cord.

2. What is the market for Neuroendoscopy?

The global Neuroendoscopy Market is poised for significant growth, projected to achieve a remarkable Compound Annual Growth Rate (CAGR) of 4.91% during the forecast period from 2024 to 2030.

3. What are the drivers for the global Neuroendoscopy market?

The Neuroendoscopy Market is slated to witness prosperity owing to factors such as the growing prevalence of neurological disorders such as brain tumors. Additionally, the growing demand for minimally invasive procedures and various advantages associated with neuroendoscopic procedures, are some of the other factors resulting in appreciable revenue growth in the Neuroendoscopy Market during the forecast period (2024-2030).

4. Who are the key players operating in the global Neuroendoscopy market?

Some of the key market players operating in the Neuroendoscopy Market include Adeor Medical AG, Machida Endoscope Co. Ltd, B. Braun SE, Schindler Endoskopie Technologie GmbH, Clarus Medical LLC, KARL STORZ, Locamed Ltd., Ackermann Instrumente GmbH, Tonglu Wanhe Medical Instruments Co., Ltd., Renishaw plc, Cliniva Healthcare, Advin Healthcare, Aesculap Inc., ClearMind Biomedical, and others.

5. Which region has the highest share in the global Neuroendoscopy market?

North America is expected to dominate the overall Neuroendoscopy Market during the forecast period, 2024 to 2030. This is due to the presence of a large patient pool suffering from various neurological disorders such as brain tumor. Additionally, the presence of developed and sophisticated healthcare infrastructure, rising technological advancements, and a highly potent market in terms of product development, and launches, are some of the key factors driving the growth of the Neuroendoscopy Market in North America.

Table of Contents

1. Neuroendoscopy Market Report Introduction

2. Neuroendoscopy Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Neuroendoscopy Market Key Factors Analysis

  • 4.1. Neuroendoscopy Market Drivers
    • 4.1.1. Rising prevalence of Neurological Disorders
    • 4.1.2. Growing demand for minimally invasive procedures and benefits associated with neuroendoscopy procedures
  • 4.2. Neuroendoscopy Market Restraints and Challenges
    • 4.2.1. High cost associated with the neuroendoscopy procedures and equipment
    • 4.2.2. Shortage of skilled neurologists and endoscopists
  • 4.3. Neuroendoscopy Market Opportunities
    • 4.3.1. Increasing technological advancement in the domain of neuroendoscopy

5. Neuroendoscopy Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. Neuroendoscopy Market Layout

  • 6.1. By Product
    • 6.1.1. Rigid Neuroendoscopes
    • 6.1.2. Flexible Neuroendoscopes
  • 6.2. By Application
    • 6.2.1. Transnasal
    • 6.2.2. Intraventricular
    • 6.2.3. Transcranial
  • 6.3. By Usability
    • 6.3.1. Reusable
    • 6.3.2. Disposable
  • 6.4. By End-User
    • 6.4.1. Hospitals
    • 6.4.2. Ambulatory Surgical Centers
    • 6.4.3. Others
  • 6.5. By Geography
    • 6.5.1. North America
      • 6.5.1.1. United States Neuroendoscopy Market Size in USD million (2021-2030)
      • 6.5.1.2. Canada Neuroendoscopy Market Size in USD million (2021-2030)
      • 6.5.1.3. Mexico Neuroendoscopy Market Size in USD million (2021-2030)
    • 6.5.2. Europe
      • 6.5.2.1. France Neuroendoscopy Market Size in USD million (2021-2030)
      • 6.5.2.2. Germany Neuroendoscopy Market Size in USD million (2021-2030)
      • 6.5.2.3. United Kingdom Neuroendoscopy Market Size in USD million (2021-2030)
      • 6.5.2.4. Italy Neuroendoscopy Market Size in USD million (2021-2030)
      • 6.5.2.5. Spain Neuroendoscopy Market Size in USD million (2021-2030)
      • 6.5.2.6. Rest of Europe Neuroendoscopy Market Size in USD million (2021-2030)
    • 6.5.3. Asia-Pacific
      • 6.5.3.1. China Neuroendoscopy Market Size in USD million (2021-2030)
      • 6.5.3.2. Japan Neuroendoscopy Market Size in USD million (2021-2030)
      • 6.5.3.3. India Neuroendoscopy Market Size in USD million (2021-2030)
      • 6.5.3.4. Australia Neuroendoscopy Market Size in USD million (2021-2030)
      • 6.5.3.5. South Korea Neuroendoscopy Market Size in USD million (2021-2030)
      • 6.5.3.6. Rest of Asia-Pacific Neuroendoscopy Market Size in USD million (2021-2030)
    • 6.5.4. Rest of the World (RoW)
      • 6.5.4.1. Middle East Neuroendoscopy Market Size in USD million (2021-2030)
      • 6.5.4.2. Africa Neuroendoscopy Market Size in USD million (2021-2030)
      • 6.5.4.3. South America Neuroendoscopy Market Size in USD million (2021-2030)

7. Neuroendoscopy Market Company and Product Profiles

  • 7.1. Adeor Medical AG
    • 7.1.1. Company Overview
    • 7.1.2. Company Snapshot
    • 7.1.3. Financial Overview
    • 7.1.4. Product Listing
    • 7.1.5. Entropy
  • 7.2. Machida Endoscope Co. Ltd
    • 7.2.1. Company Overview
    • 7.2.2. Company Snapshot
    • 7.2.3. Financial Overview
    • 7.2.4. Product Listing
    • 7.2.5. Entropy
  • 7.3. B. Braun SE
    • 7.3.1. Company Overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Financial Overview
    • 7.3.4. Product Listing
    • 7.3.5. Entropy
  • 7.4. Schindler Endoskopie Technologie GmbH
    • 7.4.1. Company Overview
    • 7.4.2. Company Snapshot
    • 7.4.3. Financial Overview
    • 7.4.4. Product Listing
    • 7.4.5. Entropy
  • 7.5. Clarus Medical LLC
    • 7.5.1. Company Overview
    • 7.5.2. Company Snapshot
    • 7.5.3. Financial Overview
    • 7.5.4. Product Listing
    • 7.5.5. Entropy
  • 7.6. KARL STORZ
    • 7.6.1. Company Overview
    • 7.6.2. Company Snapshot
    • 7.6.3. Financial Overview
    • 7.6.4. Product Listing
    • 7.6.5. Entropy
  • 7.7. Locamed Ltd.
    • 7.7.1. Company Overview
    • 7.7.2. Company Snapshot
    • 7.7.3. Financial Overview
    • 7.7.4. Product Listing
    • 7.7.5. Entropy
  • 7.8. Ackermann Instrumente GmbH
    • 7.8.1. Company Overview
    • 7.8.2. Company Snapshot
    • 7.8.3. Financial Overview
    • 7.8.4. Product Listing
    • 7.8.5. Entropy
  • 7.9. Tonglu Wanhe Medical Instruments Co., Ltd.
    • 7.9.1. Company Overview
    • 7.9.2. Company Snapshot
    • 7.9.3. Financial Overview
    • 7.9.4. Product Listing
    • 7.9.5. Entropy
  • 7.10. Renishaw plc.
    • 7.10.1. Company Overview
    • 7.10.2. Company Snapshot
    • 7.10.3. Financial Overview
    • 7.10.4. Product Listing
    • 7.10.5. Entropy
  • 7.11. Cliniva Healthcare
    • 7.11.1. Company Overview
    • 7.11.2. Company Snapshot
    • 7.11.3. Financial Overview
    • 7.11.4. Product Listing
    • 7.11.5. Entropy
  • 7.12. Advin Healthcare
    • 7.12.1. Company Overview
    • 7.12.2. Company Snapshot
    • 7.12.3. Financial Overview
    • 7.12.4. Product Listing
    • 7.12.5. Entropy
  • 7.13. Aesculap Inc.
    • 7.13.1. Company Overview
    • 7.13.2. Company Snapshot
    • 7.13.3. Financial Overview
    • 7.13.4. Product Listing
    • 7.13.5. Entropy
  • 7.14. ClearMind Biomedical
    • 7.14.1. Company Overview
    • 7.14.2. Company Snapshot
    • 7.14.3. Financial Overview
    • 7.14.4. Product Listing
    • 7.14.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Neuroendoscopy Market in Global (2021-2030)
  • Table 3: Neuroendoscopy Market in Global by Product (2021-2030)
  • Table 4: Neuroendoscopy Market in Global by Application (2021-2030)
  • Table 5: Neuroendoscopy Market in Global by Usability (2021-2030)
  • Table 6: Neuroendoscopy Market in Global by End-User (2021-2030)
  • Table 7: Neuroendoscopy Market in Global by Geography (2021-2030)
  • Table 8: Neuroendoscopy Market in North America (2021-2030)
  • Table 9: Neuroendoscopy Market in North America by Country (2021-2030)
  • Table 10: Neuroendoscopy Market in the United States (2021-2030)
  • Table 11: Neuroendoscopy Market in Canada (2021-2030)
  • Table 12: Neuroendoscopy Market in Mexico (2021-2030)
  • Table 13: Neuroendoscopy Market in Europe (2021-2030)
  • Table 14: Neuroendoscopy Market in Europe by Country (2021-2030)
  • Table 15: Neuroendoscopy Market in France (2021-2030)
  • Table 16: Neuroendoscopy Market in Germany (2021-2030)
  • Table 17: Neuroendoscopy Market in the United Kingdom (2021-2030)
  • Table 18: Neuroendoscopy Market in Italy (2021-2030)
  • Table 19: Neuroendoscopy Market in Spain (2021-2030)
  • Table 20: Neuroendoscopy Market in the Rest of Europe (2021-2030)
  • Table 21: Neuroendoscopy Market in Asia-Pacific (2021-2030)
  • Table 22: Neuroendoscopy Market in Asia-Pacific by Country (2021-2030)
  • Table 23: Neuroendoscopy Market in China (2021-2030)
  • Table 24: Neuroendoscopy Market in Japan (2021-2030)
  • Table 25: Neuroendoscopy Market in India (2021-2030)
  • Table 26: Neuroendoscopy Market in Australia (2021-2030)
  • Table 27: Neuroendoscopy Market in South Korea (2021-2030)
  • Table 28: Neuroendoscopy Market in Rest of Asia-Pacific (2021-2030)
  • Table 29: Neuroendoscopy Market in the Rest of the World (2021-2030)
  • Table 30: Neuroendoscopy Market in RoW by Region (2021-2030)
  • Table 31: Neuroendoscopy Market in the Middle East (2021-2030)
  • Table 32: Neuroendoscopy Market in Africa (2021-2030)
  • Table 33: Neuroendoscopy Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Neuroendoscopy Market in Global (2021-2030)
  • Figure 3: Neuroendoscopy Market in Global by Product (2021-2030)
  • Figure 4: Neuroendoscopy Market in Global by Application (2021-2030)
  • Figure 5: Neuroendoscopy Market in Global by Usability (2021-2030)
  • Figure 6: Neuroendoscopy Market in Global by End-User (2021-2030)
  • Figure 7: Neuroendoscopy Market in Global by Geography (2021-2030)
  • Figure 8: Neuroendoscopy Market in North America (2021-2030)
  • Figure 9: Neuroendoscopy Market in North America by Country (2021-2030)
  • Figure 10: Neuroendoscopy Market in the United States (2021-2030)
  • Figure 11: Neuroendoscopy Market in Canada (2021-2030)
  • Figure 12: Neuroendoscopy Market in Mexico (2021-2030)
  • Figure 13: Neuroendoscopy Market in Europe (2021-2030)
  • Figure 14: Neuroendoscopy Market in Europe by Country (2021-2030)
  • Figure 15: Neuroendoscopy Market in France (2021-2030)
  • Figure 16: Neuroendoscopy Market in Germany (2021-2030)
  • Figure 17: Neuroendoscopy Market in the United Kingdom (2021-2030)
  • Figure 18: Neuroendoscopy Market in Italy (2021-2030)
  • Figure 19: Neuroendoscopy Market in Spain (2021-2030)
  • Figure 20: Neuroendoscopy Market in the Rest of Europe (2021-2030)
  • Figure 21: Neuroendoscopy Market in Asia-Pacific (2021-2030)
  • Figure 22: Neuroendoscopy Market in Asia-Pacific by Country (2021-2030)
  • Figure 23: Neuroendoscopy Market in China (2021-2030)
  • Figure 24: Neuroendoscopy Market in Japan (2021-2030)
  • Figure 25: Neuroendoscopy Market in India (2021-2030)
  • Figure 26: Neuroendoscopy Market in Australia (2021-2030)
  • Figure 27: Neuroendoscopy Market in South Korea (2021-2030)
  • Figure 28: Neuroendoscopy Market in Rest of Asia-Pacific (2021-2030)
  • Figure 29: Neuroendoscopy Market in the Rest of the World (2021-2030)
  • Figure 30: Neuroendoscopy Market in RoW by Region (2021-2030)
  • Figure 31: Neuroendoscopy Market in the Middle East (2021-2030)
  • Figure 32: Neuroendoscopy Market in Africa (2021-2030)
  • Figure 33: Neuroendoscopy Market in South America (2021-2030)
  • Figure 34: Market Drivers
  • Figure 35: Market Barriers
  • Figure 36: Marker Opportunities
  • Figure 37: PORTER'S Five Force Analysis